(Q33556448)

28 July 2017

Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis (English)

1 reference

28 July 2017

0 references

Hakala M

1

1 reference

28 July 2017

van Assendelft AH

2

1 reference

28 July 2017

Ilonen J

3

1 reference

28 July 2017

Jalava S

4

1 reference

28 July 2017

Tiilikainen A

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

45

1 reference

28 July 2017

3

1 reference

28 July 2017

177-182

1 reference

Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

DR antigens and rheumatoid arthritis: a study of two populations.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

HLA DR antigens and gold toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

HL-A antigens and disease. Statistical and genetical considerations.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Some Characteristics of RA Patients with and Without Side Effects Due to Gold Treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Stimulatory and cytotoxic activity on human adult and fetal lymphocytes by heterologous antihuman fetal lymphocyte sera

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

HLA-Dw4 and Rheumatoid Arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Pulmonary damage associated with gold therapy. A report of two cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Pulmonary Infiltrates Associated With Gold Therapy: Report Of A Case

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Agranulocytosis, levamisole, and HLA-B27.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

Diffuse pulmonary injury associated with gold treatment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001849

DR antigens and gold toxicity in white rheumatoid arthritis patients

31 October 2018

1 reference

12 December 2020

Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities

1 reference

12 December 2020

Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis

1 reference

12 December 2020

1958 Revision of diagnostic criteria for rheumatoid arthritis

1 reference

12 December 2020

Letter: HL-A 27 and rheumatoid arthritis

1 reference

12 December 2020

Agranulocytosis, levamisole, and HLA-B27

1 reference

12 December 2020

Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs

1 reference

12 December 2020

Psoriasis and HLA-Cw6

1 reference

12 December 2020

Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition

1 reference

12 December 2020

HLA-Dw1 and BfF as protective markers in multiple sclerosis.

1 reference

12 December 2020

Alveolitis during Chrysotherapy for Rheumatoid Arthritis

1 reference

12 December 2020

Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.45.3.177

1 reference

release_nzrp4zhlorcyfls7mlcevu3ljy

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nzrp4zhlorcyfls7mlcevu3ljy

24 November 2022

mapped directly with Wikidata item

PMCID

1001849

1 reference

28 July 2017

1 reference